Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Gordon ER, Kwinta BD, Schreidah CM, Fahmy LM, Adeuyan O, Queen D, et al. Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes. Leuk Lymphoma. 2024;65(1):48-54.

Ávila-Gómez P, Shingai Y, Dash S, Liu C, Callegari K, Meyer H, et al. Molecular and functional alterations in the cerebral microvasculature in an optimized mouse model of sepsis-associated cognitive dysfunction. bioRxiv. 2024.

Magro CM, Kalomeris T, Shreve CR, Geyer JT, Patel SS. Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration. Leuk Lymphoma. 2024:1-9.

Demko N, Geyer JT. Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry? Cytometry B Clin Cytom. 2024;106(5):331-346.

Barisic D, Chin CR, Meydan C, Teater M, Tsialta I, Mlynarczyk C, et al. ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell. 2024.

Gokozan HN, Scognamiglio T. Solitary fibrous tumor of deep parotid gland preoperatively classified as salivary gland neoplasm of uncertain malignant potential by the Milan system for reporting salivary gland cytopathology: A common diagnosis for a rare entity. Diagn Cytopathol. 2024.

Geyer JT. Current Challenges in the Characterization of Myeloid Neoplasms. Pathobiology. 2024;91(1):5-7.

Chan AT, Maya TR, Park C, Tak K, Liberman N, Jain RH, et al. Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses. JACC Cardiovasc Imaging. 2024;17(2):128-145.

Lacunza E, Ahuja A, Coso OA, Abba M, Ramos JC, Cesarman E, et al. Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiation. J Med Virol. 2024;96(5):e29684.

O'Neill KA, Dugue A, Abreu NJ, Balcer LJ, Branche M, Galetta S, et al. Relapsing White Matter Disease and Subclinical Optic Neuropathy: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurol Neuroimmunol Neuroinflamm. 2024;11(2):e200194.